• Contact Form
  • help@soleburystrat.com
  • Login
Logo2
  • Events
  • Companies
  • Blog
  • Service
    • Help with Credentials
Logo2
Sign in with LinkedIn
Request new Password.
Presenter Access
Unsupported Browser. Please use Google Chrome, Mozilla Firefox, or Microsoft Edge to submit meeting requests. Microsoft Internet Explorer is not supported due to its outdated JavaScript engine.
Categories & Filter
  • All Posts
  • {{ value.title }}
  • Clear Categories



  • Preamble [SYSTEM]
  • Fund & Investor Interest
  • Street Moves
  • Solebury Trout Updates
  • Market Commentary
  • IPO News
  • Expert Interactions
  • Banker Comments & Notes
  • Conference Snippet
  • Industry Snippets
  • Social Media
  • Solebury Trout Talks

  • Scoop: SR One crew completes a complicated spinout from GlaxoSmithKline. And now they have a $500M fund to invest on their own
  • EndpointNews - The pandemic IPOs keep rolling, as Generation, Avidity, Vaxcyte each claim 200M+
  • COVID19 Resources - free to access
  • LSP closes largest ever European life sciences fund at $600 million
  • Highland Capital Management LP files for Chapter 11 bankruptcy -- Bloomberg
  • Versant Ventures Enables Launch of Vensana Capital to Focus on Medtech Sector
  • HBM Partners Biopharma M&A Update
  • Barron: Ziad Bakri interview (T. Rowe Health Sciences Fund)
  • WSJ - Beleaguered Money Managers Find Bright Spot in ESG
  • WSJ - NYSE Cuts Fees to Court Biotech Listings Away From Nasdaq
  • WSJ: SEC Moves to Ease Fraud Audits for Smaller Companies
  • Life Sci VC - Why Reputation Is More Important Than Ever For Biotech Companies … And What You Can Do About It
  • How can Donnelley Financial Solutions (DFIN) help Life Sciences companies accelerate their deal execution?
  • CBS 60 Minutes - Could gene therapy cure sickle cell anemia?
  • Barron's: Why Big Pharma Is Diving Into Gene Therapy
  • The Wall Street Journal - A Big, Fatty Opportunity for Big Pharma
  • Bloomberg - Biotech Stocks Are Enjoying Their Best-Ever Start to the Year
  • Bloomberg - Citadel, Point72 Hammered by Monthly Losses in November Comedowb
  • Bloomberg - Balyasny Cuts 125 People as Hedge Fund Bleeds Assets
  • The drug pricing maze - Axios
  • New York Aims to Jump-Start City's Drug Industry With Tower Pact
  • Private equity giant Blackstone buys Clarus in biopharma push - Fierce biotech
  • September 2018 Sell-Side Update
  • Let’s Throw a Patent-Burning Party
  • IRS considering revising rules requiring spin-offs generate revenue to qualify for tax-free status -- Bloomberg
  • Biotech Success Stories: Achieving Value From Your Company - Trailblazer Webinar Series
  • Trout Update on MiFiD II

© Copyright 2023 by Solebury Strategic Communications | Current user: n/a, [en_US] | Privacy Policy